Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2021

Medicamentos antivíricos e antifúngicos

Contract value
€19,916.67
Signed on
9 February 2021
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 7503531

PUBLISHED SUBJECT

41/168/2021 - Medicamentos antivíricos e antifúngicos

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
Laboratórios Pfizer · Tax ID 500162166
Awardee
Generis · Tax ID 508107997
Awardee
LAB. MEDINFAR, SA. · Tax ID 500384045
Awardee
HIKMA FARMACÊUTICA (PORTUGAL) SA. · Tax ID 502266791
Awardee
SIDEFARMA SOC IND EXP FARMAC · Tax ID 500717419

Values and timeline

Contract price
€19,916.67
Procedure base price
€40,759.01
Total effective price
Not reported on Portal BASE
Publication date
26 February 2021
Award date
9 February 2021
Signing date
9 February 2021
Performance period
360 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Preço ou custo
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
Framework agreement
Medicamentos antivíricos e antifúngicos
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
5160720

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts